Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.37%
Change (1 year)
Categories
EPS for Sage Therapeutics (SAGE)
EPS in 2023 (TTM): -$9.92
According to Sage Therapeutics 's latest financial reports the company's current EPS (TTM) is -$9.92. In 2022 the company made an earnings per share (EPS) of -$8.98 a decrease over its 2021 EPS that were of -$7.80.
EPS history for Sage Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$9.92 | 10.47% |
| 2022 | -$8.98 | 15.13% |
| 2021 | -$7.80 | -167.18% |
| 2020 | $11.61 | -186.77% |
| 2019 | -$13.38 | 66.21% |
| 2018 | -$8.05 | 13.06% |
| 2017 | -$7.12 | 51.49% |
| 2016 | -$4.70 | 38.64% |
| 2015 | -$3.39 | 104.43% |
| 2014 | -$1.66 | 52.1% |
| 2013 | -$1.09 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | -$1.69 | -82.96% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $6.39 | -164.42% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $1.92 | -119.35% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | $0.92 | -109.27% | 🇺🇸 USA |